Search Prime Contracts

75A50324C00006

Definitive Contract

Overview

Government Description
ANTHIM (OBILTOXAXIMAB)
Place of Performance
Parsippany, NJ 7054 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Not Competed
Analysis Notes
Sole Source This Definitive Contract was awarded sole source to Elusys Therapeutics because the government beleives this product / service is critical for industrial mobiliation or is essential R&D.
Elusys Therapeutics was awarded Definitive Contract 75A50324C00006 (75A503-24-C-00006) for Anthim (OBILTOXAXIMAB) worth up to $124,650,623 by the HHS Office of the Assistant Secretary for Preparedness and Response in May 2024. The contract has a duration of 3 years and was awarded through solicitation Anthrax Antitoxin (monoclonal antibody) full & open with NAICS 325412 and PSC 6505 via sole source acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $55,400,560.

Status
(Open)

Last Modified 5/17/24
Period of Performance
5/1/24
Start Date
4/30/27
Current End Date
4/30/27
Potential End Date
33.0% Complete

Obligations and Backlog
$69.3M
Total Obligated
$69.3M
Current Award
$124.7M
Potential Award
56% Funded
$0.0
Funded Backlog
$55.4M
Total Backlog

Award Hierarchy

Definitive Contract

75A50324C00006

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75A50324C00006

Opportunity Lifecycle

Procurement history for 75A50324C00006

Transaction History

Modifications to 75A50324C00006

People

Suggested agency contacts for 75A50324C00006

Competition

Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Mobilization, Essential R&D
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
ELP1DCK8L191
Awardee CAGE
1WEK8
Agency Detail
Awarding Office
75A503 ASPR/ORM-SNS
Funding Office
75A503
Created By
hhsterrireed
Last Modified By
hhskgolden2
Approved By
hhskgolden2

Legislative

Legislative Mandates
None Applicable
Performance District
NJ-11
Senators
Robert Menendez
Cory Booker
Representative
Mikie Sherrill
Modified: 5/17/24